Nov 17, 2020
Bioprinting holds enormous promise in medicine in areas such as tissue engineering, regenerative medicine and drug discovery.
Oct 26, 2020
The Victorian Cancer Biobank (VCB) is a crucial part of the medical research landscape supporting researchers throughout Australia and around the world with the aim of delivering better clinical outcomes to people suffering with cancer.
Sep 24, 2020
AXT is excited to add the Vieworks range of bio-imaging systems to their preclinical imaging product portfolio. Their in-vivo imaging systems provide outstanding performance in bioluminescent and fluorescent imaging and represents excellent value.
Sep 22, 2020
Medical research is an important part of the Australian research landscape and one that AXT is committed to supporting.
Sep 07, 2020
With Australia having a vast wealth of mineral resources and mining being a key factor in the nations' economy, understanding mineral deposits is of key importance.
Aug 31, 2020
AXT has further consolidated its position as a diversified supplier of life science products with the addition of LabTIE International's innovative range of laboratory products and consumables.
Aug 20, 2020
AXT and Delmic are proud of a first in the world installation.
Aug 17, 2020
AXT are proud to announce that they have partnered with France-based Poietis to bring their next-generation bioprinting platforms to Australia.
May 27, 2020
AXT are proud to announce that they have just expanded their life science product portfolio with the addition of Fluicell's innovative tissue engineering systems.
Mar 04, 2020
AXT in conjunction with DENSsolutions have installed the first Climate in situ TEM platform in Australia. The installation took place at the Australian Centre of Microscopy and Microanalysis at the University of Sydney.